Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,Molecular Medicine,General Medicine
Reference108 articles.
1. R.L. Siegel, K.D. Miller, A. Jemal, Cancer statistics, 2020. CA Cancer J Clin 70, 7–30 (2020)
2. J. Prat, New insights into ovarian cancer pathology. Ann Oncol 23 (Suppl 10), x111–x117 (2012)
3. U.A. Matulonis, A.K. Sood, L. Fallowfield, B.E. Howitt, J. Sehouli, B.Y. Karlan, Ovarian cancer. Nat Rev Dis Primers 2, 1–22 (2016)
4. N.H. Chobanian, V.L. Greenberg, J.M. Gass, C.P. Desimone, J.R. Van Nagell, S.G. Zimmer, Histone deacetylase inhibitors enhance paclitaxel-induced cell death in ovarian cancer cell lines independent of p53 status. Anticancer Res 24, 539–545 (2004)
5. P. Filippakopoulos, J. Qi, S. Picaud, Y. Shen, W.B. Smith, O. Fedorov, E.M. Morse, T. Keates, T.T. Hickman, I. Felletar, M. Philpott, S. Munro, M.R. McKeown, Y. Wang, A.L. Christie, N. West, M.J. Cameron, B. Schwartz, T.D. Heightman, N. La Thangue, C.A. French, O. Wiest, A.L. Kung, S. Knapp, J.E. Bradner, Selective inhibition of BET bromodomains. Nature 468, 1067–1073 (2010)
Cited by
31 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献